- Home
- PWR vs COR Comparison
PWR vs COR Comparison
Compare PWR & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PWR | COR |
|---|---|---|
| Founded | 1997 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.6B | 57.4B |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | PWR | COR |
|---|---|---|
| Price | $446.75 | $355.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 13 |
| Target Price | ★ $423.20 | $360.62 |
| AVG Volume (30 Days) | 858.0K | ★ 1.1M |
| Earning Date | 02-19-2026 | 02-04-2026 |
| Dividend Yield | 0.10% | ★ 0.69% |
| EPS Growth | ★ 24.72 | 5.71 |
| EPS | 6.75 | ★ 7.96 |
| Revenue | $27,191,171,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $19.56 | $7.17 |
| Revenue Next Year | $12.35 | $6.57 |
| P/E Ratio | $64.78 | ★ $43.96 |
| Revenue Growth | ★ 18.72 | 9.31 |
| 52 Week Low | $227.08 | $235.77 |
| 52 Week High | $473.99 | $377.54 |
Technical Indicators
Market Signals| Indicator | PWR | COR |
|---|---|---|
| Relative Strength Index (RSI) | 55.15 | 63.11 |
| Support Level | $426.59 | $333.79 |
| Resistance Level | $442.00 | $349.55 |
| Average True Range (ATR) | 12.96 | 6.79 |
| MACD | 1.86 | 1.74 |
| Stochastic Oscillator | 84.86 | 97.60 |
Price Performance
Historical ComparisonAbout PWR Quanta Services Inc.
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two segments: electric infrastructure and underground utility and infrastructure.
About COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.